Guyasuta Investment Advisors Has Upped By $744,320 Its Johnson & Johnson (JNJ) Stake; Olin (OLN)’s Sentiment Is 1.09

June 14, 2018 - By Ina Campbell

Olin Corporation (NYSE:OLN) Logo

Guyasuta Investment Advisors Inc increased Johnson & Johnson (JNJ) stake by 2.59% reported in 2018Q1 SEC filing. Guyasuta Investment Advisors Inc acquired 5,815 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Guyasuta Investment Advisors Inc holds 230,350 shares with $29.52 million value, up from 224,535 last quarter. Johnson & Johnson now has $328.03 billion valuation. The stock decreased 0.27% or $0.33 during the last trading session, reaching $122.3. About 2.27M shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 14, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: ; 29/03/2018 – Natrecor (nesiritide; Johnson & Johnson) Drug Analysis 2018 – ResearchAndMarkets.com; 17/04/2018 – Johnson & Johnson 1Q EPS $1.60; 25/04/2018 – J&J GETS COURT TO THROW OUT $151 MILLION DEPUY HIP VERDICT; 22/03/2018 – Global Low Temperature Sterilization Market Analysis & Outlook 2018-2022 Featuring Johnson & Johnson, 3M, Getinge and Steris – ResearchAndMarkets.com; 03/04/2018 – Malaysia Eyewear Market Analysis & Outlook 2011-2021 – Key Players are Luxottica, Johnson & Johnson and Hoya Corp – ResearchAndMarkets.com; 14/05/2018 – STAT Plus: AbbVie and J&J reverse course on a price hike in face of criticism; 16/04/2018 – J&J: STUDY FOUND ESKETAMINE SHOWED IMPROVEMENTS IN SUICIDALITY; 22/03/2018 – EpigenCare Named as Johnson & Johnson Innovation Finalist in Skincare Challenge; 16/04/2018 – JANSSEN – COS TO SHARE DEVELOPMENT COSTS, COMMERCIAL PROFITS AND LOSSES; ADDITIONAL TERMS OF AGREEMENT NOT DISCLOSED; 15/05/2018 – Nutriband Inc. Announces the Appointment of Dr. Jeff Patrick as Chief Scientific Officer and to Head of Advisory Board

Olin Corp (OLN) investors sentiment decreased to 1.09 in Q1 2018. It’s down -0.20, from 1.29 in 2017Q4. The ratio is negative, as 140 investment professionals increased and opened new equity positions, while 128 decreased and sold their stakes in Olin Corp. The investment professionals in our database now hold: 138.66 million shares, down from 144.77 million shares in 2017Q4. Also, the number of investment professionals holding Olin Corp in top ten equity positions was flat from 3 to 3 for the same number . Sold All: 45 Reduced: 83 Increased: 95 New Position: 45.

Since January 1, 0001, it had 4 buys, and 2 insider sales for $46,190 activity.

Proxima Capital Management Llc holds 4.49% of its portfolio in Olin Corporation for 270,000 shares. Kensico Capital Management Corp owns 8.17 million shares or 4.41% of their US portfolio. Moreover, Messner & Smith Theme Value Investment Management Ltd Ca has 2.9% invested in the company for 57,543 shares. The Connecticut-based Iridian Asset Management Llc Ct has invested 2.03% in the stock. Oarsman Capital Inc., a Wisconsin-based fund reported 122,648 shares.

Olin Corporation manufactures and distributes chemical products in the United States and internationally. The company has market cap of $5.07 billion. It operates through three divisions: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. It has a 9.31 P/E ratio. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products, and potassium hydroxide.

Analysts await Olin Corporation (NYSE:OLN) to report earnings on July, 30. They expect $0.40 earnings per share, up 3,900.00% or $0.39 from last year’s $0.01 per share. OLN’s profit will be $66.88 million for 18.96 P/E if the $0.40 EPS becomes a reality. After $0.15 actual earnings per share reported by Olin Corporation for the previous quarter, Wall Street now forecasts 166.67% EPS growth.

Ratings analysis reveals 50% of Olin’s analysts are positive. Out of 2 Wall Street analysts rating Olin, 1 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. The lowest target is $29.33 while the high is $37.0. The stock’s average target of $33.17 is 9.33% above today’s ($30.34) share price. OLN was included in 3 notes of analysts from September 7, 2016. The firm earned “Underperform” rating on Wednesday, September 7 by Longbow. On Friday, February 10 the stock rating was maintained by Cowen & Co with “Outperform”.

The stock decreased 1.14% or $0.35 during the last trading session, reaching $30.34. About 433,108 shares traded. Olin Corporation (OLN) has risen 10.00% since June 14, 2017 and is uptrending. It has underperformed by 2.57% the S&P500. Some Historical OLN News: ; 23/05/2018 – Olin at Vertical Research Partners Materials Conference Jun 14; 01/05/2018 – Olin Corp 1Q EPS 12c; 22/05/2018 – REG-Aktia Bank plc: Managers’ transactions — Sam Olin- as part of the share-based incentive scheme; 23/04/2018 – S&PGR Upgrades Olin To ‘BB+’; Outlook Stable; Debt Rtgs Raised; 01/05/2018 – OLIN 1Q ADJ OPER EPS 12C, EST. 20C; 01/05/2018 – OLIN 1Q ADJ EBITDA $240.3M, EST. $244.4M; 12/04/2018 – Olin Presenting at Wells Fargo Industrials Conference May 8; 01/05/2018 – Olin Corp Backs 2018 Adjusted EBITDA $1.25B; 25/04/2018 – Olin Announces New Lead Director; 23/04/2018 – Olin Presenting at UBS Mini Conference May 21

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Recent Purchase: Johnson & Johnson” on June 14, 2018, also Seekingalpha.com with their article: “Johnson & Johnson (JNJ) Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript)” published on June 12, 2018, Seekingalpha.com published: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” on June 01, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fool.com and their article: “Better Buy: Verizon Communications Inc. vs. Johnson & Johnson” published on June 11, 2018 as well as Seekingalpha.com‘s news article titled: “Many Large US Firms Sell, Hire And Invest More Overseas Than In US And They Have To Think Globally, Not …” with publication date: June 14, 2018.

Since February 15, 2018, it had 0 insider buys, and 1 sale for $20.17 million activity. 155,342 shares valued at $20.17M were sold by Stoffels Paulus on Thursday, February 15.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Piper Jaffray on Monday, October 2. Jefferies maintained it with “Hold” rating and $14500 target in Friday, July 14 report. The firm has “Buy” rating by Jefferies given on Tuesday, January 16. The stock has “Buy” rating by Deutsche Bank on Wednesday, April 18. Wells Fargo maintained Johnson & Johnson (NYSE:JNJ) on Friday, January 12 with “Buy” rating. Leerink Swann maintained the shares of JNJ in report on Thursday, May 17 with “Buy” rating. Deutsche Bank upgraded the shares of JNJ in report on Tuesday, September 29 to “Buy” rating. Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating on Thursday, August 4. Jefferies has “Hold” rating and $119 target. The stock has “Buy” rating by Wells Fargo on Tuesday, February 6. The stock has “Sell” rating by Atlantic Securities on Friday, July 21.

Investors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Birch Hill Inv Advisors Limited Liability Company invested in 2.33% or 219,732 shares. Grubman Wealth holds 2,246 shares or 0.21% of its portfolio. Burt Wealth Advsrs has 0.85% invested in Johnson & Johnson (NYSE:JNJ) for 13,098 shares. Bennicas Associates accumulated 9,000 shares or 1.03% of the stock. Credit Suisse Ag reported 4.69 million shares stake. Excalibur Management Corp has invested 5.14% in Johnson & Johnson (NYSE:JNJ). 57,699 were reported by Chatham Cap Group. Nj State Employees Deferred Compensation Plan reported 1.14% in Johnson & Johnson (NYSE:JNJ). Creative Planning holds 412,829 shares. Factory Mutual Insur Communications holds 965,500 shares. Kayne Anderson Rudnick Investment Mgmt Lc has invested 0.02% in Johnson & Johnson (NYSE:JNJ). Atlanta Cap Mgmt Company L L C holds 0.3% or 451,083 shares in its portfolio. Barnett & owns 1,175 shares for 0.08% of their portfolio. 29,780 are owned by Mengis Cap Management Incorporated. Lsv Asset Management reported 8.92 million shares.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: